18 th International Myeloma Workshop Prospective comparison of contemporary whole body MRI and FDG PET/CT for disease detection and correlation with markers of disease burden in myeloma: Results of the iTIMM trial Martin F. Kaiser, Nuria Porta, Bhupinder Sharma, Daniel Levine, Dow-Mu Koh, Kevin Boyd, Charlotte Pawlyn, Angela M. Riddell, Kate Downey, Alison Bonner, Veronica A Morgan, Simon Stern, Lydia Jones, Betty Cheung, Charalampia Kyriakou, Pawel Kaczmarek, Jessica Mary Winfield, Matthew D. Blackledge, Wim J.G. Oyen, Christina Messiou Institute of Cancer Research, London, United Kingdom; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital, London, United Kingdom; Epsom and St Helier University Hospitals, Carshalton, United Kingdom; Croydon UniversityHospital, Croydon, United Kingdom; University College London Hospitals, London, United Kingdom; Surrey and Sussex NHS Healthcare Trust, Redhill, United Kingdom; The Department of Radiology and Nuclear Medicine, Rijnstate, Arnhem.